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Abstract 
Patient experience of care remains an important indicator of health care quality. Although studies show care experiences 
are associated with health outcomes for some conditions, the situation for cancer is unclear. New datasets on cancer 
patients in the US, Canada, and UK linking information on experiences and survival may enable an exploration of any 
association. This review aimed to identify studies linking any aspect of cancer patients’ experiences to their survival, to 
inform future analyses. We performed a systematic review using Medline database from January 1998 until March 2018. 
The settings included outpatient oncology clinics, primary care, hospitals, and cancer centres. The participants included 
adult patients from different demographic groups. 16 Studies (ten observational, two clinical trials, two qualitative, and 
two consecutive case series) describing a wide range of settings, populations and methods met our inclusion criteria. 
Patients’ experiences were mostly linked to survival in quantitative studies. Satisfaction with care and psychosocial 
support were the aspects of experience associated with survival. Although positive associations between experience and 
survival were more common, negative and lack of association findings were also reported. Overall, there was no 
agreement on the strength, direction of the association, and the type of measurements to use. In conclusion, a wide 
range of studies suggest a relationship may exist between patients’ experiences of cancer care and their survival. 
However, this relationship is complex and methodological challenging to study. Future research should carefully 
consider different aspects of patient experience and care and the way in which they may affect cancer survival. 
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Introduction 
 
Patient-centred care is now recognised as an essential 
component of high quality healthcare.1 Patient experience 
is an important measure and interpretation of how patient-
centred care principles and practice are perceived by 
patients receiving health care.2 A considerable international 
literature on patient experience has grown in response to 
the increasing emphasis on and measurement of patients’ 
experiences in healthcare systems.3–5 Wolf and colleagues 
point out that “patient experience reflects occurrences and 
events that happen independently and collectively across 
the continuum of care”.6 The link between patient 
experience and health outcomes has been investigated in 
many different healthcare settings.7 Several studies across a 
range of health conditions and different populations have 
documented associations between patient experience and 
care effectiveness,8,9 patient safety,10 and mortality.11 
 
Cancer outcomes are influenced by cancer type, stage of 
disease, comorbid conditions at diagnosis, and the quality 
of cancer care the patient receives.12 The possibility of an 
association between patient experience and survival has 
not often been investigated in a cancer care setting. 
Sociodemographic and systemic variations in patient 
experience with cancer care have been documented in 
several studies from the United States13,14 and England.15–
19 Some of the factors associated with poorer experience 
such as lower socioeconomic status are also associated 
with poorer outcomes raising the question of whether an 
independent association exists between patients’ 
experiences of cancer care and their survival. 
 
Several systematic reviews have focused on cancer patient 
experience. Sanders and others20 conducted a review to 
investigate the available instruments used to measure the 
cancer patient experience of health care. They found that 
there is a lack of studies measuring cancer patient 
experience in a systematic and consistent way.20 Mollica 
and colleagues performed a scoping review of cancer 
patient experience, considering only the core domains of 
Services Consumer Assessment of Healthcare Providers 
and Systems (CAHPS) – a patient experience instrument 
used widely in the USA, that summarized the literature and 
identified possible future directions for research.21 Their 
review identified a gap in the research literature regarding 
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the relationship between cancer care experience and 
survival. Thus, the aim of this study was to search the 
medical literature systematically to determine how patients' 
experiences of cancer care have been linked to survival. 
We hoped that this would inform 1) directions for future 
research in this area and 2) the development of analyses of 
the recently available linked patient experience and patient 
survival databases.22,23 
 
Method and approach 
 
Patient experience is a term that refers to different 
dimensions of the interaction between patients and the 
healthcare system and has not yet been recognized as a 
subject heading in health science databases. Previous 
systematic reviews on patient experience have also used 
different dimensions to extract different types of 
literature.10,21 We chose to use the patient experience 
dimensions presented by Doyle and colleagues since they 
combined patient experience dimensions from the 
Institute of Medicine, Picker Institute, and National 
Institute for Health and Care Excellence (NICE).10  
 
We identified possible words and terms that might denote 
literature on dimensions of patient experience (Table 1 and 
Box 1). We used cancer survival as the outcome, and a 
range of different terms to extract possible relevant 
literature (Table 1). We limited this first review to Medline 
due to the complexity of duplicating the same terms in 
other databases and assumed that most of quantitative 
articles investigating survival would be indexed in Medline. 
After combining these terms together, and using the 
Medline database, we identified 1830 papers that were 
published between January 1998 and March 2018. Titles 
and abstracts for all 1830 articles were first read by one 
reviewer (AS) who excluded 1683 as not at all relevant. 
The remaining 147 were read and a shortlist of 26 full text 
articles prepared (Figure 1).  
 
In addition, since patient experience is an emerging 
research field, we considered eligible papers that have been 
referred to in the following popularly cited articles that 
linked patients’ experiences to their health outcomes,8,9 in 
the scoping review about cancer experience with care,21 
and in a popular systematic review that linked patients’ 
experience to clinical safety and effectiveness across many 
health conditions including several types of cancer.10 
Following that, we used Google Scholar features, “Cited 
by” and “Related Articles”, to review the citation histories 
of these popular articles to consider any additional paper 
that has linked patients’ experiences to cancer survival 
(Figure 1). By doing so, we found an additional nine 
articles that met our inclusion criteria.  
 
 
Table 1. Patient experience terms used in combination with cancer(neoplasm) and cancer survival terms 
 
Cancer patient experience aspects terms Cancer term Survival terms 
Patient centered care 
Physician-patient relations  
Patient preference 
Patient participation 
Patient satisfaction 
Quality of health care 
Patient experience 
Surveys and questionnaires  
Decision making 
Health care surveys 
Continuity of patient care 
Communication 
Social support 
Empathy 
Neoplasm Treatment outcome 
Survival 
Disease-Free Survival 
Survival Analysis 
Survival Rate 
Mortality 
Prognosis 
 
 
Box 1. Full electronic search strategy for patient experience terms used in Medline database 
 
Patient-Centered Care/ OR Physician-Patient Relations/ Patient Preference/ or Patient Participation/ Patient Satisfaction/ 
Or "Quality of Health Care"/ or "patient* experience*".mp./ OR "Surveys and Questionnaires"/ Decision Making/ or 
Health Care Surveys/ OR “Continuity of Patient Care"/ Communication/ Patient Preference/ Social Support/ Empathy/ 
AND Neoplasms/ AND treatment outcome/ OR Survival/ or Disease-Free Survival/ or Survival Analysis/ or Survival 
Rate/ OR Mortality/ OR Prognosis/ 
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The preliminary shortlist of eligible research papers were 
initially chosen by the first reviewer (SA), and these were 
read independently by another reviewer (ED) and 
discussed with a third (ML). The first reviewer then 
extracted the following information (type of study, sample 
size, country, setting, study aim, cancer type, unit of 
analysis, patient experience aspect and method used, 
primary outcomes and method used, and results) from 
each study and these aspects were independently assessed 
by reviewers (ED, ML) to determine the final eligible 
articles. In addition, although many assessment tools were 
available, we chose the Effective Public Health Practice 
Project Assessment Tool25 to assess the quality of the 
included quantitative studies due to the variety in design of 
included studies (Appendix 1). 
 
We included studies that linked any aspect of patient 
experience with cancer survival. This included studies 
where the experience was reported by patients, doctors, 
GPs, or extracted from healthcare systems records. Patient 
Reported Outcomes Measures (PROM) studies were 
excluded on the basis that they do not ask questions about 
patient experiences, but rather about symptoms and 
outcomes. All types of studies such as cross sectional, 
cohort and case control studies that used validated tools or 
specifically developed interviews to measure or assess 
patient experience dimensions and linked that to a 
measure of cancer survival were included. The studies 
were categorized into four groups, based on their main 
aims and how they linked patients’ experiences to cancer 
survival: (1) preferences for information about cure or 
treatment, (2) psychosocial support (3) a care system or 
team intervention, and (4) patient satisfaction. 
 
Results 
 
A total of 16 journal articles met the inclusion criteria 
including 11 observational studies,26,27,36,28–35 one 
quantitative content analysis,37 two clinical trials,38,39 and 
Figure 1. Systematic review flowchart using PRISMA24 
 
 
Figure 1: Systematic review flowchart using PRISMA24 
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two consecutive case series.40,41 The included studies 
varied widely in methods, population and findings. Table 2  
(found at the end of the article) summarizes the study 
aims, study population, methods, patients experience 
aspects, and study outcomes. 
 
Preferences for information about cure or 
treatment 
 
Two studies - one cohort34 and one cross sectional33 - 
focused on patients’ expectations for cancer cure, their 
treatment preference, relations with oncologists and how 
they perceived quality of care to be. Gleason et al 
examined whether lung, colorectal, breast, lymphoma, 
head and neck, liver, and leukaemia cancer patients’ 
expectations for cure influence their decisions to follow 
treatment recommendations and whether these are 
affected by oncologist–patient alliance.33 The authors 
found that patients who expected a cure were more likely 
to report an intention to follow oncologists’ treatment 
recommendations.33 Additionally, Rose and colleagues 
focused on the difference between older and middle-aged 
late-stage cancer patients in terms of care preference, 
relations with oncologist, perceived quality of life and 
estimation of survival.34 This study concluded that both 
middle-aged and older patients and their physicians had 
different perspectives regarding perceived quality of life, 
physician estimation for patents’ survival, and patient’s 
estimation for their survival.34 In addition, the majority of 
patients in both groups had treatment goals of relieving 
pain or discomfort.34 
 
Psychosocial support 
 
Four studies (one clinical trial,39 two observational 
studies,35,36 and one qualitative study37) focused on 
psychosocial support and patients’ survival. Burns et al 
investigated whether emotional support was predictive of 
survival among patients with incurable breast, lung, and 
gastrointestinal, prostate, and haematological cancer. They 
found that survival (follow-up 36 months) was 
significantly shorter among those with two to three 
confidants than among those with more or fewer 
confidants (p=0.031). They also found emotional support 
to be an independent prognostic indicator of survival.35 
Guo et al determined the benefits of psychosocial 
interventions for breast, lung, cervical, endometrial cancer 
patients who were undergoing radiotherapy39. Although no 
significant difference between cases and controls in terms 
of survival was found, the psychological intervention 
significantly reduced symptoms of anxiety (p < 0.05) and 
depression (p < 0.05), as well as improved elements of 
quality of life such as global health status (p < 0.05) in the 
intervention group.39 In addition, in a qualitative analysis, 
Buis and colleagues analysed 3717 posts on the internet, 
made by patients with lung, pancreatic, melanoma, and 
thyroid cancer, to determine how emotional and 
informational support contents differ in online 
communities for cancers with high and low five-year 
survival.37 Within the posts containing social support 
content, high-survival cancer communities had more 
content including emotional support (75%) than low-
survival communities (66%). By contrast, low-survival 
communities had more informational content (46%) than 
high survival communities (36%).37 Finally, Cunningham 
and colleagues focused on the variation in psychological 
responses to the diagnosis of life-threatening cancer and 
whether that is related to survival in several types of 
cancers.36 Even though this study had a limited sample size 
(n=22), patients who had a lower psychological score had 
a statistically significant median survival of 1.29 years while 
those with higher psychological score had median survival 
of 2.85 years. The authors attributed this to psychological 
self-help activities such as relaxation, meditation, and 
spiritual activities.36 
 
Health care system and team intervention 
 
Two studies (one cross sectional study32 and one non-
randomised clinical trial38) focused on the cancer care 
system, or team interventions and their association with 
cancer survival. McCarthy and colleagues investigated 
various aspects of the performance of breast, colorectal, 
lung and prostate cancer services and whether they were 
related to survival at the hospital level or specialist services 
level.32 They combined five different datasets including 
waiting time, compliance with standards, cancer patient 
experience survey, hospital routinely collected data, and 
cancer survival data.32 Their analysis showed that higher 
breast cancer one-year survival (p=0.04) and lung cancer 
five-year survival (p=0.014) at cancer network level was 
associated with higher overall dissatisfaction scores.32 In 
addition, Daly and colleagues conducted a non-
randomized clinical trial to evaluate the effects of 
interdisciplinary cancer support team on quality of life and 
quality of care among patients with advanced colorectal, 
lung, and gynaecologic cancers.38 The study found no 
significant difference between cases and controls in quality 
of care; but that the five-year survival probability was the 
most significant effect on quality of care outcomes (p = 
0.04).38 
 
Patient satisfaction 
 
Eight studies, (five cross sectional studies,26–28,30,31 two 
consecutive case series,40,41 and one prospective cohort 
study29), were conducted at Cancer Treatment Centres of 
America hospitals, and focused on the association between 
patient satisfaction and survival. This research assessed 
different types of patient satisfaction including patient 
satisfaction with service quality and patient satisfaction 
with quality of life. After controlling for variables such as 
cancer stage at diagnosis, previous treatment history, and 
treatment location, patients who had higher satisfaction 
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with their service quality had a lower risk of mortality than 
those with low satisfaction score in the following cancers: 
colorectal (hazard ratio (HR) = 0.74; 95% CI: 0.58–0.95; p 
= 0.02),27 pancreatic (HR= 0.63; 95% CI: 0.51–0.79; p = 
0.001),31 breast (HR= 0.71; 95 % CI 0.57–0.87; p=0.001),28 
and non-small cell lung (HR = 0.71; 95% CI: 0.60–0.85; p 
< 0.001).29 Later, Gupta and colleagues added self-rated 
health as an independent variable and examined the same 
association in non-small cell lung30 and prostate cancers 
independently.26 They found that self-rated-health was 
significant in predicting survival in non-small cell lung 
cancer (HR = 0.75; 95% CI: 0.57 to 0.99; p=0.04) and 
prostate26 cancer (HR= 0.25; 95 % CI: 0.11-0.58; 
p=0.001). Thus, self-rated-health confounded the 
relationship between patient satisfaction and survival in 
non-small cell lung cancer30 and replaced patient 
satisfaction in prostate cancer26 as a predictor of survival. 
In two other studies conducted at the same cancer centre, 
Lis and colleagues assessed whether patient satisfaction 
with quality of life can predict survival in advanced 
colorectal41 and pancreatic cancers.40 After controlling for 
cancer stage at diagnosis (in both) and previous treatment 
history (only in colorectal), baseline patient satisfaction 
with quality of life was prognostic for survival in advanced 
colorectal cancer (p=0.0003),41 but not in pancreatic 
cancer (p=0.053).40 Overall, findings from these studies 
support the importance of assessing the relationship 
between patient satisfaction, self-rated health, and quality 
of life measures in cancer patent experience. Yet, the 
inconsistency in the results is puzzling. It might be a result 
of differing effects of type of cancer, pathways of possible 
influence for patient experience, care offered at different 
treatment centres, and different measuring instruments 
used in the studies. All of these possibilities emphasize the 
need for a systematic and consistent way to assess the 
association between cancer patient experience and 
subsequent survival. 
 
Discussion  
The aim of this study was to systematically review the 
literature to determine how cancer patient experience has 
been linked to cancer survival. We hoped to inform the 
direction of research in this area and analysis of the 
recently available linked patient experience and patient 
survival databases. Overall, this review revealed a variety 
of different methods and perspectives on how cancer 
patients’ experiences were linked to survival across 
different types of cancer. Patients’ satisfaction, 
psychosocial support, satisfaction with quality of life were 
the most common aspects of patient experience found to 
be associated with survival in the literature. The studies we 
included in our review showed positive, negative or lack of 
association cancer patient experience and subsequent 
survival. Thus, these studies suggest a relation exists 
between patients’ experiences of cancer care and survival, 
but it is a complex and methodological challenging one to 
study.  
Previous systematic reviews have identified several gaps in 
the cancer patient experience research field. Sanders et al 
found that there is a lack of studies measuring cancer 
patient experience in systematic and consistent ways.20 We 
found a wide range of methods, settings, and population 
used to measure cancer patients experience and to link it 
to subsequent survival. Moreover, Mollica et al conducted 
a review to summarize the cancer patient experience 
literature, indicate research gaps, and provide future 
research directions.21 They identified a gap in research 
examining relationships between cancer experience and 
survival. Our study contributes to closing this gap by 
finding that cancer patients’ experiences have been linked 
to survival in a number of studies and revealing a complex 
and challenging relationship to unpick. In addition, Doyle 
et al demonstrated a positive association between patient 
experience and patient safety and clinical effectiveness 
across a wide range of disease areas including several types 
of cancer.10 Several studies included in our review 
suggested a positive association between cancer patient 
experience and patient survival. However, as our review 
shows a clear heterogeneity across all aspects of linking 
cancer patient experience with subsequent survival, not all 
of these studies gave a clear overall indication of the 
magnitude of any observed association.  
 
Our findings show the difficulty of determining the 
association between patient experience and survival. While 
the finding is a novel one for cancer care settings, several 
studies in other health settings have raised concerns that 
any possible association between patient experience and 
health outcomes may be biased by patient characteristics, 
or affected by reverse causation or confounded by factors 
within the healthcare system or related to the patient’s 
health situation.7,42,43 These issues were found in several 
studies included in this review. For example, the 
conclusion that cancer survival can be predicted by 
measuring patient self-rated health or patient satisfaction 
with services quality or with quality of life was 
contradicted by findings within studies conducted by the 
same research group.26–31,40,41 Despite the different cancer 
types in these studies, such a contradiction in the final 
conclusions demonstrates the importance of using 
appropriate methodological tools when assessing 
association between patient experience and health 
outcomes in cancer setting as the case in other health 
settings. 
 
The present study has several strengths. First, it is, to our 
knowledge, the first study that examines how cancer 
patient experience has been linked to cancer survival. 
Second, using the methods presented by Doyle et al ,10 we 
extended the patient experience dimensions to include 
those presented by the Picker Institute, NICE to catch all 
dispersed terms. In addition, since the association between 
patient experience and health outcome is an emerging field 
and not well established in the literature, we included 
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relevant articles from similar systematic reviews and 
popular studies in the field to make sure we included all 
relevant studies in the field.  
 
However, our study is subject to several limitations. This 
systematic review was limited to English language articles 
in Medline database and did not include other medical 
databases such as CINAHL, which might include some 
eligible studies. This exclusion was due to the complexity 
and lack of uniformity of the MeSH terms for patient 
experience dimensions in different medical databases. This 
is an area for future research to review the current used 
MeSH terms for measuring patient experience given the 
importance of measuring these elements in current 
research. Second, some of the included studies in our 
review had several methodological limitations within them 
including sample size, absence of a control group and not 
considering reverse causation. For example, several of the 
patient satisfaction studies we included reported 
contradictory results across several types of cancer and 
needed an appropriate reverse causation analysis using 
systematic and consistent instruments. However, we 
decided to include them since the main aim of this study is 
to examine how patients experience have been linked to 
survival in the literature, not to draw a conclusion on the 
strength and direction of association between cancer 
patient experience and cancer survival. Finally, we cannot 
exclude the possibility of publication bias for significant 
positive or negative association findings. 
 
Conclusion  
 
The possible association between patient experience with 
cancer care and subsequent outcomes continues to emerge 
as an important topic. The availability of the UK22, 
Canada44, and US23 datasets that contain information on 
both cancer patients’ experiences and their survival status 
will enable researchers to explore such an association. This 
review highlights the methodological complexity of 
determining a possible relationship between cancer patient 
experience and subsequent survival. While future research 
is recommended to examine the strength and direction of 
this association, appropriate conceptual and 
methodological consideration is warranted before studying 
or drawing a conclusion on this association.  
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Citation  Type of 
study, 
sample 
size, 
country 
Setting Study aim Cancer type Unit of 
analysis 
Patient 
experience 
aspect and 
method used 
Primary 
Outcomes and 
method used 
Result on 
association and 
notes  
Buis, et al 
(2011). 
Comparison 
of social 
support 
content 
within 
online 
communities 
for high-and 
low-
survival-rate 
cancers. 
CIN: 
Computers, 
Informatics, 
Nursing, 
29(8), 461-
467 
3717 posts 
made by 
patients in 
online 
cancer 
support 
forums, 
USA. 
Internet 
(Yahoo and 
the 
Association 
of Cancer 
Online 
Resources).  
How 
emotional and 
informational 
support 
content differs 
in online 
communities 
for cancers 
with high and 
low 5-year 
relative survival 
rates.  
Lung, 
pancreatic, 
melanoma, 
and thyroid  
Individual 
internet 
posts  
Quantitative 
content analysis 
of emotional 
and 
informational 
support needs 
expressed were 
recorded by two 
independent 
coders.  
Analysis of 
whether the 
cancer 
communities 
with high or 
low 5-year 
survival rate 
made more 
posts about 
needs for 
emotional or 
informational 
support using 
descriptive 
statistics and 
chi-square test.  
The relationship 
between more 
emotional support 
comments and 5-
year survival rate 
was significant. 
Within the posts 
containing social 
support content, 
high-survival rate 
communities 
contained more 
emotional support 
(75%) content 
than low-survival 
communities 
(66%). In 
addition, low-
survival rate 
communities had 
more 
informational 
content (46%) 
than high survival 
rate communities 
(36%) 
rate communities 
(36%). 
Rose, J. H., 
et al (2004). 
Perspectives, 
preferences, 
care 
practices, 
and 
outcomes 
among older 
and middle-
aged 
patients with 
late-stage 
cancer. 
Journal of 
clinical 
oncology, 
22(24), 
4907-4917 
Prospective 
cohort 
study, 1416 
patients, 
USA. 
Five 
teaching 
hospitals in 
USA 
To evaluate 
relationships 
among 
physician and 
cancer patient 
survival 
estimates, 
patients' 
perceived 
quality of life, 
care 
preferences, 
and outcomes, 
and how they 
vary across 
middle-aged 
and older 
patient groups. 
Late- stage 
cancer, types 
not 
mentioned. 
Patient  Perspectives 
were measured 
by assessing: 
patient’s survival 
estimate, 
physician’s 
survival estimate 
and patient’s 
perceived quality 
of life.  Care 
practice was 
measured by 
assessing 
discussion about 
aggressive care 
and therapeutic 
intervention. 
Patient’s 
preference was 
measured by 
assessing their 
preference for 
cardiopulmonary 
resuscitation.  
 
Outcome was 
measured by 
readmission to 
hospital and 
death in 6- 
month 
timeframe. 
Patients’ 
preferences for 
treatment to 
extend their lives, 
did not translate 
to longer survival 
in both older and 
middle-aged 
patients. In 
contrast, 
physicians were 
less optimistic 
about patients’ 
survival in both 
age groups.  In 
addition, majority 
of patients in both 
groups preferred 
treatment goal of 
reducing pain and 
discomfort. 
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Gleason, et 
al (2009). 
The 
influence of 
patient 
expectations 
regarding 
cure on 
treatment 
decisions. 
Patient 
education 
and 
counseling, 
75(2), 263-
269 
Cross 
sectional, 
study of 
101 
patients, 
USA. 
Outpatient 
oncology 
clinics at two 
National 
Cancer 
Institute 
designed 
comprehensive 
cancer centers.   
To examine 
whether cancer 
patients’ 
expectations for 
cure prior to 
interacting with 
their oncologist 
influence their 
decisions to 
follow treatment 
recommendations 
and to examine if 
patients’ 
expectations for 
cure are affected 
by the strength of 
the oncologist–
patient alliance or 
the extent to 
which 
companions (if 
present) share 
patients’ 
expectations for 
cure. 
Lung, 
colorectal, 
breast, 
lymphoma, 
head / neck, 
liver, leukemia 
and other. 
Patient and 
companion  
(1) To assess 
expectations for 
cure, patients 
and 
companions 
were asked four 
questions 
independently: 
if they expected 
the cancer to be 
cured, or will 
not worsen but 
not cured, or 
symptoms will 
be relieved but 
cancer will not 
be cured, or if 
they do not 
know what to 
expect.  
(2) Oncologist 
patient alliance 
assessed by 
KAAS scale, 
which measures 
rapport, trust, 
closeness with 
oncologist, level 
of information, 
clarity, 
responsiveness, 
amount of 
hope provided 
by oncologist, 
and how 
organized is the 
oncologist. 
Patient decision to 
follow 
oncologist’s 
treatment 
recommendation 
assessed by self-
report at phone 
interview and 
categorized as no 
intention, some 
intention, and 
intention to 
follow treatment 
recommendations.  
Patients who 
expected a cure 
were more likely to 
report an intention 
to follow 
oncologist’s 
treatment 
recommendation 
when their alliance 
with the oncologist 
was not strong and 
when their 
companions do 
not believe they 
will be cured. In 
addition, this study 
concludes that a 
complex 
interaction of 
patient and 
companion, or 
oncologist and 
patient alliance and 
expectations 
influence patients’ 
decisions. 
Burns, C. 
M., et 
al(2005). 
Does 
emotional 
support 
influence 
survival? 
Findings 
from a 
longitudinal 
study of 
patients 
with 
advanced 
cancer. 
Supportive 
care in 
cancer, 
13(5), 295-
302. 
Cross 
sectional 
study, 163 
patients, 
Australia 
Teaching 
hospital in 
Canberra, 
Australia 
To investigate 
whether 
emotional 
support was 
predictive of 
survival duration 
among patients 
diagnosed with 
incurable cancers.  
Breast, lung, 
gastrointestinal, 
prostate, 
hematological, 
ovary and 
other.   
Patients 
aged 18 
years or 
more and 
diagnosed 
with 
incurable 
cancers. 
Emotional 
support was 
assessed by a 
specific survey 
consisting of 
three items: 
sharing feelings 
with others, if 
yes, with 
whom, is there 
anyone else to 
share feeling 
with. 
Cancer survival 
was assessed at 6, 
12, 18, 24, 30, 30, 
36 months from 
study entry. 
Number of 
confidents (0-1, 2-
3, 4+) at entry 
time was 
predictive of 
survival duration 
after adjusting for 
primary cancer site 
and other 
variables.  
Specifically, Using 
two or three 
confidants as the 
reference group, 
the relative risk  
of a shorter 
survival was: 0.44 
for patients with 
0-1 confidants and 
0.60 for those with 
four or more 
confidants.  
Emotional support 
appeared to be an 
independent 
prognostic 
indicator of 
survival after 
accounting for sex, 
age, cancer type, 
and treatment 
modality.  
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Cunningham, 
et al (2000). 
A 
prospective, 
longitudinal 
study of the 
relationship 
of 
psychological 
work to 
duration of 
survival in 
patients with 
metastatic 
cancer. 
Psycho‐
Oncology, 
9(4), 323-
339. 
Prospective 
study, 22 
patients, 
Canada 
Psychotherapy 
sessions took 
place at 
different times 
and different 
locations led 
by two of the 
authors. 
To describe, in 
a more reliable 
and rigorous 
way, the 
individual 
variation in 
psychological 
responses to 
the 
predicament of 
life-threatening 
cancer, and to 
relate this 
variability to 
survival 
duration, using 
a case-oriented, 
correlative 
approach. 
Breast, 
pancreatic, 
cervical, 
colorectal, 
ovarian, 
multiple 
melanoma. 
Patient 
with 
incurable 
cancers  
Variation in 
patient’s 
response to 
the 
psychotherapy 
sessions 
assessed by 
three main 
methods: 
notes taken by 
investigators, 
written 
homework, 
and individual 
interview 
conducted by 
two 
investigators 
for two and 
half hour 
weekly for 1 
year. The 
session 
consisted of 
three 
components: 
support, 
homework, 
and group 
psychotherapy.  
Survival rate 
after following 
up for about 
five years.  
Although the 
sample size is 
limited for this 
study (n=22) the 
study concluded 
that after 
controlling for 
the severity of 
disease there a 
strong 
association 
between longer 
survival and 
psychological 
factors. Those 
who had lower 
psychological 
score had a 
median survival 
of 1.29 years 
while those with 
higher 
psychological 
score had median 
survival of 2.85 
years. The 
physiological 
factors related to 
the involvement 
of cancer patients 
in psychological 
self-help 
activities such as 
relaxation, 
meditation, and 
spiritual activities 
at home.   
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Daly, et al 
(2013). Clinical 
trial of a 
supportive 
care team for 
patients with 
advanced 
cancer. Journal 
of pain and 
symptom 
management, 
46(6), 775-784. 
Non-
randomized 
Clinical trial, 
511 patients, 
USA. 
Case 
Western 
Reserve 
University 
and 
University 
Hospitals 
Case 
Medical 
Center, 
Seidman 
Cancer 
Center, 
Cleveland, 
OH, USA. 
To evaluate the 
effect of an 
interdisciplinary 
cancer support 
team (CST) on 
quality of care 
and quality of life 
in patients with 
advanced 
cancers. 
Colorectal, 
lung, and 
gynecologic 
cancers. 
Patients 
aged 18 
years and 
over and 
diagnosed 
with 
cancer at 
stage 3 or 
4. 
To measure the 
effect of the 
interdisciplinary 
cancer support 
team (CST) 
intervention, 
which consists of 
advanced practice 
nurse, social 
workers, spiritual 
care counselor. A 
quasi-
experimental 
design was used 
to measure the 
quality of care 
and quality of life 
outcomes.  
Quality of 
end of life 
care using 
the National 
Quality 
Forum 
(NQF) 
standards. 
Survival 
expectation 
was in the 
regression 
analysis as 
part of the 
end of life 
measures.   
There was no 
significance 
difference in 
survival between 
patients receiving 
interdisciplinary 
cancer support 
team (CST) and 
usual care on the 
quality of care 
indicators. In 
addition, patients 
with higher 
survival 
expectancy in the 
intervention arm 
had the greatest 
improvement in 
health-related 
quality of life 
scores compared 
to other groups.  
Guo, Z., et al 
(2013). The 
benefits of 
psychosocial 
interventions 
for cancer 
patients 
undergoing 
radiotherapy. 
Health and 
Quality of Life 
outcomes, 
11(1), 121. 
Randomized 
clinical trial, 
178 patients, 
China. 
Hospital of 
Guilin 
medical 
university, 
China. 
To determine the 
benefits of 
psychosocial 
interventions for 
cancer patients 
who received 
radiation therapy. 
Breast, lung, 
cervical, 
endometrial, 
and other. 
Patients 
aged 18 or 
older, 
diagnosed 
with 
cancer and 
who would 
go under 
radiation 
therapy.  
Psychological 
intervention 
delivered by a 
clinician, a nurse 
and a radiation 
therapist and 
consisted of 
Psycho-
education, 
cognitive-
behavioral 
therapy, and 
supportive–
expressive 
therapy.  
Depression 
assessed by 
Zung self-
rating 
depression 
scale, 
anxiety 
assessed by 
self-rating 
anxiety 
scale, quality 
of life 
assessed 
with 
(EORTC 
QLQ-C30), 
and survival 
analysis. 
The 
psychological 
intervention 
significantly 
reduced the level 
of depression and 
anxiety, 
improved the 
elements of 
quality of life 
such emotional 
and physical 
functioning. 
However, there 
was no significant 
difference in the 
survival between 
the two groups.   
McCarthy, et 
al. (2007). Is 
the 
performance 
of cancer 
services 
influenced 
more by 
hospital 
factors or by 
specialization?. 
Journal of 
public health, 
30(1), 69-74 
Cross 
sectional 
study, 
England, five 
independent 
national data 
sets.  
Data 
collected 
from 152 
hospitals 
and 
survival 
data came 
from 
National 
Cancer 
Registry.: 
5891 
patients 
with 
colorectal 
4011 with 
lung, 25 
772 breast, 
and 10 992 
with 
prostate 
cancer 
completing 
the English 
cancer 
experience 
survey 
were 
included. 
To examine 
whether cancer 
service 
performance 
across a range of 
quality indicators 
including patient 
satisfaction was 
related more to 
the hospital level, 
or specialist 
services level 
within the 
hospital across 
different tumor 
types.  
Breast, 
colorectal, 
lung and 
prostate 
Patients 
who 
responded 
to the 
survey and 
their 
survival 
estimates.  
Satisfaction with 
care from 
National Cancer 
Patient Survey 
dataset and in 
hospital mortality 
and population-
level survival 
from National 
Cancer Registry. 
The 
different 
data sets 
were 
compared at 
both cancer 
network and 
hospital 
levels. In 
addition, 1- 
5-year 
relative 
survival was 
calculated 
for patients 
diagnosed in 
England 
between 
1996 and 
2001 
(followed up 
to the end 
of 31 
December 
2002). 
Variation was 
statistically 
significant across 
hospitals and 
networks in all 
measures. Breast 
cancer 1-year 
survival (p=0.04) 
and lung cancer 
5-year survival 
(p=0.014) were 
associated with 
Higher 
dissatisfaction 
scores. 
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Lis, et al (2015). The 
Relationship 
between Patient 
Satisfaction with 
Service Quality and 
Survival in Non-
Small Cell Lung 
Cancer–Is Self-
Rated Health a 
Potential 
Confounder?. PloS 
one, 10(7), e0134617. 
 
Cross 
sectional 
study, 778 
patients, 
USA  
Four Cancer 
Treatment 
Centers of 
America 
hospitals 
(CTCA 
hospitals were 
CTCA 
Eastern, 
CTCA 
Midwestern, 
CTCA 
Southwestern 
and CTCA 
Western).  
To examine 
whether better 
self-rated 
health (SRH) 
confounds the 
relationship 
between 
patients’ 
satisfaction 
and their 
survival in 
non-small cell 
lung cancer. 
Non-small 
cell lung 
cancer. 
All, non-
small cell 
lung cancer 
adult 
patients 
who were 
seen at 
Cancer 
Treatment 
Centers 
American 
hospitals 
between 
July 2011 
and March 
2013, were 
eligible for 
this study. 
Patients’ 
satisfaction 
assessed by a 
paper-based 
questionnaire 
developed by 
the authors in 
2006. 
Patient survival 
between the 
dates a patient 
completed the 
survey and the 
date of 
patient’s death 
from any cause 
or the date of 
last contact or 
last known to 
be alive. 
 
Patients who 
were satisfied 
with their care 
had lower risk 
of mortality 
(hazard ratio 
= 0.75; 95% 
CI: 0.57 to 
0.99; p=0.04) 
compared to 
those who 
were not 
satisfied. Also, 
patients who 
had better 
self-rated 
health had a 
significantly 
lower risk of 
mortality (HR 
= 0.61; 95% 
CI: 0.46 to 
0.81; p 
=0.001). On 
multivariate 
analysis, only 
self-rated 
health was 
significant 
(hazard ratio 
= 0.67; 95% 
CI: 0.50 to 
0.89; p = 
0.007). Thus, 
it confounded 
the 
association 
between 
patients’ 
satisfaction 
and survival.  
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Gupta, et al 
(2012). The 
relationship 
between 
patient 
satisfaction 
with service 
quality and 
survival in 
pancreatic 
cancer. Patient 
preference and 
adherence, 6, 
765 
 
Cross 
sectional 
study, 496 
patients, 
USA 
Cancer 
Treatment 
Centers of 
America® 
(CTCA) 
hospitals, 
USA.  
 
 
To evaluate the 
relationship 
between 
patient 
satisfaction 
with cancer 
care service 
quality and 
survival in 
pancreatic 
cancer patients.  
 
Pancreatic 
cancer  
Adult 
pancreatic 
cancer 
patients who 
were seen at 
one of three 
Cancer 
Treatment 
Centers of 
America® 
(CTCA) 
hospitals 
(CTCA 
Eastern, 
CTCA 
Midwestern, 
and CTCA 
Southwestern) 
between July 
2007 and 
December 
2010.   
Patients’ 
satisfaction 
assessed by a 
paper-based 
questionnaire 
developed by 
the authors in 
2006.  
 
Patient survival 
between the 
date a patient 
completed the 
survey and the 
date of 
patient’s death 
from any cause 
or the date of 
last contact or 
last known to 
be alive. 
 
Patients who 
had higher 
satisfaction 
with care 
services had 
lower 
mortality 
(hazard ratio 
= 0.63; 95% 
confidence 
interval: 0.51–
0.79; P = 
0.001) than 
those who 
had lower 
satisfaction 
score after 
controlling for 
stage, 
treatment 
history, and 
treatment 
center. 
 
Gupta, et al 
(2014). 
Patient 
satisfaction 
with service 
quality as a 
predictor of 
survival 
outcomes in 
breast cancer. 
Supportive 
Care in 
Cancer, 
22(1), 129-
134 
Cross 
sectional 
study, 
1521 
patients, 
USA. 
Cancer 
Treatment 
Centers of 
America 
(CTCA) 
hospitals, 
USA. 
To evaluate the 
relationship 
between 
patient-
reported 
satisfaction 
with service 
quality and 
their survival 
of breast 
cancer.  
Breast cancer  Adult breast 
cancer 
patients who 
were seen at 
one 
of three 
Cancer 
Treatment 
Centers of 
America 
(CTCA) 
hospitals 
(CTCA 
hospitals were 
CTCA 
Eastern, 
CTCA 
Midwestern, 
and 
CTCA 
Southwestern 
between July 
2007 and 
December 
2010.  
Patients 
satisfaction 
assessed by a 
paper-based 
questionnaire 
developed by 
the authors in 
2006.  
 
Patient survival 
between the 
dates a patient 
completed the 
survey and the 
date of 
patient’s death 
from any cause 
or the date of 
last contact or 
last known to 
be alive. 
 
Patients who 
had higher 
satisfaction 
with care 
services had 
lower 
mortality 
(hazard ratio 
= 0.71; 95 % 
CI 0.57–0.87; 
p =0.001) 
than those 
who had 
lower 
satisfaction 
score after 
controlling for 
stage, 
treatment 
history, and 
treatment 
center.  
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Lis, et al 
(2006). Can 
patient 
satisfaction 
with quality of 
life predict 
survival in 
advanced 
colorectal 
cancer?. 
Supportive 
care in cancer, 
14(11), 1104-
1110 
A 
consecutive 
case series, 
177 
patients, 
USA. 
Cancer 
Treatment 
Centers of 
America 
(CTCA) 
hospitals, 
USA. 
To evaluate the 
association 
between 
patient 
satisfaction 
with quality of 
life and 
survival in 
colorectal 
cancer patients 
undergoing 
care in a 
community 
hospital 
comprehensive 
cancer center. 
 
Colorectal 
cancer  
Adult 
colorectal 
cancer 
patients 
treated at 
Cancer 
Treatment 
Centers of 
America at 
Midwestern 
Regional 
Medical 
Center 
between 
April 2001 
and 
November 
2004. 
Quality of life 
assessed by 
QLI scale, 
which covers 
health and 
physical, 
social and 
economic, 
psychological 
and spiritual, 
and family. 
Each one of 
these areas 
has questions 
about 
satisfactions. 
Patient survival 
between the 
dates a patient 
first visits the 
hospital and 
the date of 
patient’s death 
from any cause 
or the date of 
last contact or 
last known to 
be alive. The 
survival data 
obtained from 
the hospital 
cancer registry.  
Patient’s 
satisfaction with 
quality of life 
provided a 
prognostic 
information in 
colorectal cancer 
care. Specifically, 
health and 
physical subscale 
was significantly 
associated with 
survival 
(p=0.0003), with 
median survival 
being 20.6 
months for high 
scores and 8.3 
for low score 
after taking in 
account the stage 
of the disease at 
diagnosis and the 
treatment 
history. 
 
Lis, et al . 
(2006). Patient 
satisfaction 
with quality of 
life as a 
predictor of 
survival in 
pancreatic 
cancer. 
International 
journal of 
gastrointestinal 
cancer, 37(1), 
35-43 
A 
consecutive 
case series, 
55 patients, 
USA. 
cancer 
Treatment 
Centers of 
America 
(CTCA) 
hospitals, 
USA. 
To evaluate the 
association 
between 
patient 
satisfaction 
with quality of 
life and 
survival in 
pancreatic 
cancer patients 
undergoing 
care in a 
community 
hospital 
comprehensive 
cancer center. 
 
Pancreatic 
cancer  
Adult 
pancreatic 
cancer 
patients 
treated at 
Cancer 
Treatment 
Centers of 
America at 
Midwestern 
Regional 
Medical 
Center 
between 
April 2001 
and 
November 
2004. 
Quality of life 
assessed by 
QLI scale, 
which covers 
health and 
physical, 
social and 
economic, 
psychological 
and spiritual, 
and family. 
Each one of 
these areas 
has questions 
about 
satisfactions. 
Patient survival 
between the 
dates a patient 
first visits the 
hospital and 
the date of 
patient’s death 
from any cause 
or the date of 
last contact or 
last known to 
be alive. The 
survival data 
obtained from 
the hospital 
cancer registry. 
No Quality of 
life subscale was 
found to be 
statistically 
significant after 
controlling for 
stage at 
diagnosis. 
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Table 2. Summary of the included studies (cont’d.) 
 
Gupta, et al 
(2013). Can 
patient 
experience 
with service 
quality predict 
survival in 
colorectal 
cancer?. Journal 
for Healthcare 
Quality, 35(6), 
37-43 
 
Cross 
sectional, 
702 
patients, 
USA  
Cancer Treatment 
Centers of 
America (CTCA) 
hospitals, USA. 
To evaluate 
the 
relationship 
between 
patient-
reported 
experience 
with service 
quality and 
survival 
colorectal 
cancer 
patients. 
Colorectal 
cancer 
Adult 
colorectal 
cancer 
patients who 
were seen at 
one 
of three 
Cancer 
Treatment 
Centers of 
America 
(CTCA) 
hospitals 
(CTCA 
hospitals were 
CTCA 
Eastern, 
CTCA 
Midwestern, 
and 
CTCA 
Southwestern) 
between July 
2007 and 
December 
2010. 
 
Patients 
satisfaction 
assessed by a 
paper-based 
questionnaire 
developed by 
the authors in 
2006. 
Patient 
survival 
between the 
dates a patient 
completed the 
survey and the 
date of 
patient’s death 
from any 
cause or the 
date of last 
contact or last 
known to be 
alive. 
Patients who 
had higher 
satisfaction 
with their 
service quality 
had lower 
mortality 
(hazard ratio 
= 0.74; 95% 
CI: 0.58–0.95; 
p = 0.02) 
than those 
who had 
lower 
satisfaction 
scores after 
controlling 
for stage, 
treatment 
history, 
gender, age, 
and treatment 
center. 
Gupta, et al 
(2015). Self-
rated health 
supersedes 
patient 
satisfaction 
with service 
quality as a 
predictor of 
survival in 
prostate 
cancer. Health 
and quality of 
life outcomes, 
13(1), 137 
Cross 
sectional 
study, 917 
patients, 
USA. 
Cancer Treatment 
Centers of 
America®(CTCA) 
hospitals, USA. 
To investigate 
whether self-
rated health 
can supersede 
patients’ 
satisfaction as 
a predictor of 
survival in 
prostate 
cancer 
patients. 
Prostate 
cancer  
Adult prostate 
cancer 
patients who 
were seen at 
one 
of four 
Cancer 
Treatment 
Centers of 
America 
(CTCA) 
hospitals 
(CTCA 
hospitals were 
CTCA 
Eastern, 
CTCA 
Midwestern, 
CTCA 
Southwestern 
and CTCA 
Western) 
between July 
2011 and 
March 2013. 
Patients 
satisfaction 
assessed by a 
paper-based 
questionnaire 
developed by 
the authors in 
2006. 
Patient 
survival 
between the 
dates a patient 
completed the 
survey and the 
date of 
patient’s death 
from any 
cause or the 
date of last 
contact or last 
known to be 
alive. 
On 
multivariate 
analysis, those 
who had 
better self-
rated health 
had lower risk 
of mortality 
(hazard ratio 
= 0.25; 95 % 
CI: 0.11-0.58; 
p = 0.001) 
compared to 
those who 
had lower 
self-rated 
health. In 
addition, 
patient 
satisfaction 
was 
significant in 
the same 
analysis 
model 
(hazard ratio 
= 0.76; 95 % 
CI: 0.40-1.5; p 
= 0.40). Thus, 
self-rated 
health 
replaced 
patient 
satisfaction as 
a predictor 
for survival.  
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Table 2. Summary of the included studies (cont’d.) 
 
Gupta, et al 
(2013). 
Patient 
satisfaction 
with service 
quality in an 
oncology 
setting: 
implications 
for 
prognosis in 
non-small 
cell lung 
cancer. 
International 
journal for 
quality in 
health care, 
25(6), 696-
703. 
Prospective 
cohort 
study, 986 
patients, 
USA. 
Cancer Treatment 
Centers of 
America®(CTCA) 
hospitals, USA. 
To evaluate 
the 
relationship 
between self-
reported 
satisfaction 
with service 
quality and 
overall 
survival in 
non-small cell 
lung cancer. 
Non-small 
cell lung 
cancer  
Adult non-
small cell lung 
cancer 
patients who 
were seen at 
one 
of three 
Cancer 
Treatment 
Centers of 
America 
(CTCA) 
hospitals 
(CTCA 
Eastern, 
CTCA 
Midwestern 
and CTCA 
Southwestern) 
between July 
20017 and 
December 
2010. 
Patients 
satisfaction 
assessed by a 
paper-based 
questionnaire 
developed by 
the authors in 
2006.  
 
Patient 
survival 
between the 
dates a patient 
completed the 
survey and the 
date of 
patient’s death 
from any 
cause or the 
date of last 
contact or last 
known to be 
alive. 
Patients who 
had higher 
satisfaction 
with their 
service quality 
with their 
service quality 
had lower 
mortality 
(hazard ratio 
= 0.71; 95% 
CI: 0.60–0.85; 
P < 0.001) 
than those 
who had 
lower 
satisfaction 
score after 
controlling 
for stage at 
diagnosis, 
treatment 
history, 
gender, and 
age. 
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Appendix 1. Quality assessment for the included quantitative studies 
 
Citation Selection 
bias 
Study 
design 
Confound
er 
blinding Data 
collection 
methods 
Drop 
outs 
Analysis Overall 
rating 
Buis, et al 
(2011) 
N/A* N/A N/A N/A N/A N/A N/A N/A 
Rose, J. 
H., et al 
(2004) 
strong moderate strong strong strong moderate strong strong 
Gleason, 
et al (2009)  
moderate weak weak strong moderate N/A strong moderate 
Burns, C. 
M., et al 
(2005) 
moderate moderate strong N/A strong strong strong strong 
Cunningha
m al 
(2000) 
weak moderate moderate strong strong weak strong moderate 
Daly, et al 
(2013) 
moderate strong strong strong strong strong strong strong 
Guo, Z., et 
al (2013) 
strong strong strong strong strong strong strong strong 
McCarthy, 
et al (2007) 
moderate weak moderate N/A strong N/A moderate moderate 
Lis, et al 
(2015) 
moderate weak weak moderate moderate weak moderate weak 
Gupta, et 
al (2012) 
moderate weak weak moderate moderate weak moderate weak 
Gupta, et 
al (2014) 
moderate weak weak moderate moderate weak moderate weak 
Lis, et al 
(2006) 
weak moderate weak moderate moderate weak moderate moderate 
Lis, et al 
(2006) 
weak moderate moderate moderate moderate weak moderate moderate 
Gupta, et 
al (2013) 
weak moderate weak moderate moderate weak moderate moderate 
Gupta, et 
al (2015) 
moderate weak weak moderate moderate weak moderate weak 
Gupta, et 
al (2013) 
moderate weak moderate moderate moderate weak moderate moderate 
 
